Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
www.DrugChatter.com/monitoring/
Is there any variation in lipitor's effectiveness as time passes?Are there specific foods that enhance lipitor's effectiveness?Are there any foods or medications that can affect lipitor's ability to inhibit fat absorption?Is non fat dairy safe with lipitor daily?Can you list diseases targeted by apotex's ruxolitinib?
See the DrugPatentWatch profile for aspirin
What concerns led to stopping aspirin before? For many people, concerns about aspirin's safety and efficacy led to stopping its use before. Some of these concerns include: Long-term risk of GI bleeding [1]: Studies have shown that long-term aspirin use can increase the risk of gastrointestinal bleeding, which can be life-threatening. This risk is particularly concerning for older adults or those with pre-existing GI conditions. Increased risk of stroke and heart attack [2]: Despite aspirin's cardiovascular benefits, high-dose or long-term use may actually increase the risk of stroke and heart attack in certain individuals. This is often due to the thinning of blood, which can lead to hemorrhage. Overlapping medications and interactions [3]: Aspirin interacts with many medications, including blood thinners, and can lead to severe bleeding or other complications. This is especially concerning for people taking multiple medications or with pre-existing bleeding disorders. Impact on kidney function [4]: Long-term aspirin use has been linked to a decrease in kidney function or exacerbation of existing kidney disease. Patient concerns and side effects [5]: Many patients experience side effects such as stomach upset, nausea, or dizziness, which can lead to discomfort and a desire to stop taking aspirin. Patent expiration and generic alternatives [6]: With the patent expiration of some popular aspirin formulations, generic alternatives are becoming more widely available. This can lead to price competition and increased access to aspirin, but also raises concerns about regulatory oversight and quality control. Sources: [1] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4411333/ [2] https://www.cochrane.org/CD003542/PNALT_long-term-regular-aspirin-in-prevention-of-cardiovascular-events#:~:text=Low%2Ddose%20aspirin%20may%20increase,gastrointestinal%20haemorrhage%20and%20bleeding. [3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4321248/ [4] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4341139/ [5] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4454446/ [6] https://www.drugpatentwatch.com/patent-expiration-timeline/ https://www.drugpatentwatch.com/
Other Questions About Aspirin :